Rezolute, Inc. (NASDAQ:RZLT) CFO Daron Evans Purchases 10,000 Shares

Rezolute, Inc. (NASDAQ:RZLT) CFO Daron Evans acquired 10,000 shares of the firm’s stock in a transaction dated Wednesday, December 18th. The stock was bought at an average price of $4.29 per share, for a total transaction of $42,900.00. Following the acquisition, the chief financial officer now owns 150,900 shares of the company’s stock, valued at approximately $647,361. This trade represents a 7.10 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link.

Daron Evans also recently made the following trade(s):

• On Thursday, December 12th, Daron Evans purchased 9,000 shares of Rezolute stock. The shares were bought at an average price of $4.60 per share, for a total transaction of $41,400.00.

Rezolute Price Performance

RZLT stock traded down $0.36 during trading on Wednesday, reaching $4.08. The company had a trading volume of 306,062 shares, compared to its average volume of 426,941. Rezolute, Inc. has a 52 week low of $0.86 and a 52 week high of $6.19. The business has a 50 day moving average of $5.15 and a 200 day moving average of $4.79. The company has a market cap of $236.41 million, a P/E ratio of -3.21 and a beta of 1.01.

Rezolute (NASDAQ:RZLT) last announced its earnings results on Thursday, September 19th. The company reported ($0.44) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.30) by ($0.14). Research analysts expect that Rezolute, Inc. will post -0.99 earnings per share for the current year.

Hedge Funds Weigh In On Rezolute

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Jeppson Wealth Management LLC purchased a new position in Rezolute during the 2nd quarter valued at about $45,000. MML Investors Services LLC bought a new position in shares of Rezolute during the third quarter valued at approximately $57,000. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of Rezolute during the third quarter valued at approximately $65,000. Virtu Financial LLC grew its stake in shares of Rezolute by 58.0% in the 3rd quarter. Virtu Financial LLC now owns 26,026 shares of the company’s stock worth $126,000 after buying an additional 9,551 shares during the last quarter. Finally, XTX Topco Ltd grew its stake in shares of Rezolute by 205.8% in the 2nd quarter. XTX Topco Ltd now owns 33,671 shares of the company’s stock worth $145,000 after buying an additional 22,660 shares during the last quarter. Hedge funds and other institutional investors own 82.97% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently weighed in on RZLT. Wedbush reissued an “outperform” rating and set a $112.00 price objective on shares of Rezolute in a research note on Monday, November 4th. JMP Securities reissued a “market outperform” rating and set a $7.00 price target on shares of Rezolute in a research report on Friday, September 20th. HC Wainwright reissued a “buy” rating and issued a $14.00 price target on shares of Rezolute in a report on Friday, November 8th. BTIG Research upped their price objective on shares of Rezolute from $13.00 to $15.00 and gave the company a “buy” rating in a research note on Tuesday, September 10th. Finally, Guggenheim started coverage on Rezolute in a report on Tuesday, August 27th. They set a “buy” rating and a $11.00 price target on the stock. Eight investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $24.13.

Rezolute Company Profile

Rezolute, Inc, a clinical stage biopharmaceutical company, develops therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder.